The Global Autoimmune Disease Diagnostics Market Size accounted for USD 4.4 Billion in 2021 and is projected to occupy a market size of USD 8.2 Billion by 2030 growing at a CAGR of 7.2% from 2022 to 2030.
Autoimmune diseases are body’s unusual immune reaction that produce antibodies which attack own tissues and cells. This usually causes destruction and weakening of healthy tissues. There are almost 80 types of autoimmune diseases existing in the world which includes rheumatoid arthritis or systemic lupus erythematosus. Auto antibody test, complete blood count, antinuclear antibody test, erythrocyte sedimentation rate and C-reactive protein are some of the tests used for diagnosis of the autoimmune disease.
Autoimmune Disease Diagnostics Market Report Statistics
- Global autoimmune disease diagnostics market revenue is projected to reach USD 8.2 Billion by 2030 with a CAGR of 7.2% from 2022 to 2030
- North America autoimmune disease diagnostics market share generated over 35% shares in 2021
- According to Johns Hopkins data, autoimmune disease affects 3% of the US population evaluating around 10 million people
- Asia-Pacific autoimmune disease diagnostics market growth will register CAGR of over 8% from 2022 to 2030
- Based on product, localized recorded over 64% of the overall market share in 2021
- Among end-use, hospitals sector generated shares of over 52% in 2021
- Increasing adoption of biosensors in diagnostic is a popular autoimmune disease diagnostics market trend that fuels the industry demand
Global Autoimmune Disease Diagnostics Market Dynamics
Market Drivers
- Growing prevalence of autoimmune disease
- Favorable government policies for research activities
- Rising awareness regarding autoimmune disorders in emerging nations
Market Restraints
- Requirement of high capital investment
- High rate of false positive results
Market Opportunities
- Rising adoption of lab automation technologies
- Advancement in healthcare technology
Autoimmune Disease Diagnostics Market Report Coverage
| Market |
Autoimmune Disease Diagnostics Market |
| Autoimmune Disease Diagnostics Market Size 2021 |
USD 4.4 Billion |
| Autoimmune Disease Diagnostics Market Forecast 2030 |
USD 8.2 Billion |
| Autoimmune Disease Diagnostics Market CAGR During 2022 - 2030 |
7.2% |
| Autoimmune Disease Diagnostics Market Analysis Period |
2018 - 2030 |
| Autoimmune Disease Diagnostics Market Base Year |
2021 |
| Autoimmune Disease Diagnostics Market Forecast Data |
2022 - 2030 |
| Segments Covered |
By Product, By Test Type, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
AstraZeneca, Inova Diagnostics Inc., Novartis AG, Abbott Laboratories, Pfizer Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc., Beckman Coulter Inc. and Sanofi-aventis. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Autoimmune Disease Diagnostics Market Growth Factors
Increasing occurrences of diseases, growing demand for better and accurate diagnostic procedures, rising awareness towards the benefits of early diagnosis, various research and development activities, and initiatives taken by favorable governments regulations are some of the key factors that are fueling the autoimmune disease diagnostics market growth across the globe. Rising occurrences of various diseases such as Hashimoto’s thyroiditis, rheumatoid arthritis and various initiatives taken by favorable governments are some of the fundamental factors driving the global autoimmune disease diagnostics market growth. According to the American Autoimmune Related Diseases Association, around 50 million people from the region are presently suffering from autoimmune related disorders. This factor is anticipated to create immense opportunities for the global autoimmune disease diagnostics market over the forecast period. Several initiatives in order to decrease the cost required to cure these diseases is also anticipated to supplement the overalls market growth during the forecast period. Furthermore, rapidly increasing occurrences of various diseases along with the growing awareness amongst the patients is the key factor that positively impacting the growth of the segment.
Development of healthcare infrastructure with the rising expenditure is expected to boost the demand for the various enhanced diagnostic methods for better treatment. The growing demand for improved and accurate diagnostic procedures due to the growth in prevalence of the various diseases is projected to boost the adoption of autoimmune disease diagnostics methods throughout the forecast period. In order to develop superior diagnosis and treatment methods the wide-ranging research and development activities are supported by government. Such research activities are expected to further spur the overall market growth. American Autoimmune Related Diseases Association has also taken the large number of initiatives in order to increase the awareness towards the advantages of early diagnosis. However, lack of skilled professionals in healthcare industry and complex and long process for diagnosis of autoimmune disease are some of the major factors that may hamper the growth of the autoimmune disease diagnostics market globally.
Autoimmune Disease Diagnostics Market Segmentation
The global autoimmune disease diagnostics market is segmented based on product, test type, end-use, and geography.
Autoimmune Disease Diagnostics Market By Product
- Systemic
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Multiple Sclerosis
- Others
- Localized
- Inflammatory Bowel Disease
- Type 1 Diabetes
- Thyroid
- Others
According to the autoimmune disease diagnostics industry analysis, localized sub-segment occupied significant market share in 2021 and will endure its dominance in the coming years. However, the systemic sub-segment is anticipated to attain fastest growth rate during the forecast timeframe from 2022 to 2030. This significant market share is related to the rapidly rising incidence of systemic autoimmune diseases, which are linked to rising morbidity and mortality rates.
Autoimmune Disease Diagnostics Market By Test Type
- Antinuclear Antibody Tests
- Autoantibody Tests
- C-reactive Protein (CRP)
- Complete Blood Count (CBC)
- Urinalysis
- Others
Based on test type, the antinuclear antibody tests sub-segment gathered maximum amount of shares in 2021 and is anticipated to witness a substantial growth rate in the forecast period. The high prevalence of immune system-damaging conditions like type 1 diabetes, myasthenia gravis, Addison's disease, rheumatoid arthritis, etc. is largely responsible for this market's dominating growth. Additionally, autoantibody tests also occupied considerable market share during the same time period.
Autoimmune Disease Diagnostics Market By End-Use
- Hospitals
- Diagnostics Centers
- Others
According to the autoimmune disease diagnostics market forecast, the hospitals sub-segment is expected to occupy a notable market share during 2022 to 2030. The hospitals' increased use of challenging interventional procedures and autoimmune disease diagnostic methods is the cause of this significant market share. Furthermore, a few diagnostic companies have recently formed strategic alliances with hospitals. This trend is predicted to continue in the coming years in order to meet the massive number of patient needs across various regions.
Autoimmune Disease Diagnostics Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Autoimmune Disease Diagnostics Market Regional Analysis
The European autoimmune disease diagnostics industry is likely to be the second-largest in the world. The growing healthcare sector, rising laboratory automation, and aggressive market-growth strategies used by key regional competitors are all factors in this region. In terms of growth, the Asia-Pacific region is likely to attain an impressive growth rate (CAGR) during the course of the forecasted years from 2022 to 2030. The Asia-Pacific region has gotten better its healthcare scenario by introducing novel diagnostic products, which are expected to increase the introduction of these diagnostic tests across the continent, propelling it to the top of the Autoimmune Disease Diagnostics Market.
Autoimmune Disease Diagnostics Market Players
The global autoimmune disease diagnostics market is characterized by the presence of experienced and established players. Some of the key players include Abbott Laboratories, AstraZeneca, Beckman Coulter Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Hemagen Diagnostics Inc., Inova Diagnostics Inc., Novartis AG, Pfizer Inc., and Sanofi-aventis.
CHAPTER 1. Industry Overview of Autoimmune Disease Diagnostics Market
1.1. Definition and Scope
1.1.1. Definition of Autoimmune Disease Diagnostics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Autoimmune Disease Diagnostics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Autoimmune Disease Diagnostics Market By Product
1.2.3. Autoimmune Disease Diagnostics Market By Test Type
1.2.4. Autoimmune Disease Diagnostics Market By End-Use
1.2.5. Autoimmune Disease Diagnostics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Autoimmune Disease Diagnostics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Autoimmune Disease Diagnostics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Autoimmune Disease Diagnostics Market By Product
4.1. Introduction
4.2. Autoimmune Disease Diagnostics Market Revenue By Product
4.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By Product, 2018-2030
4.2.2. Systemic
4.2.2.1. Systemic Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Rheumatoid Arthritis
4.2.2.2.1. Rheumatoid Arthritis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Systemic Lupus Erythematosus (SLE)
4.2.2.3.1. Systemic Lupus Erythematosus (SLE) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.4. Psoriasis
4.2.2.4.1. Psoriasis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.5. Multiple Sclerosis
4.2.2.5.1. Multiple Sclerosis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.6. Others
4.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Localized
4.2.3.1. Localized Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.2. Inflammatory Bowel Disease
4.2.3.2.1. Inflammatory Bowel Disease Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.3. Type 1 Diabetes
4.2.3.3.1. Type 1 Diabetes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.4. Thyroid
4.2.3.4.1. Thyroid Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3.5. Others
4.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Autoimmune Disease Diagnostics Market By Test Type
5.1. Introduction
5.2. Autoimmune Disease Diagnostics Market Revenue By Test Type
5.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By Test Type, 2018-2030
5.2.2. Antinuclear Antibody Tests
5.2.2.1. Antinuclear Antibody Tests Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. C-reactive Protein (CRP)
5.2.3.1. C-reactive Protein (CRP) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.4. Autoantibody Tests
5.2.4.1. Autoantibody Tests Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.5. Complete Blood Count (CBC)
5.2.5.1. Complete Blood Count (CBC) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.6. Urinalysis
5.2.6.1. Urinalysis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Autoimmune Disease Diagnostics Market By End-Use
6.1. Introduction
6.2. Autoimmune Disease Diagnostics Market Revenue By End-Use
6.2.1. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Diagnostics Centers
6.2.3.1. Diagnostics Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Autoimmune Disease Diagnostics Market By Country
7.1. North America Autoimmune Disease Diagnostics Market Overview
7.2. U.S.
7.2.1. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
7.2.2. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
7.2.3. U.S. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
7.3.2. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
7.3.3. Canada Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Autoimmune Disease Diagnostics Market By Country
8.1. Europe Autoimmune Disease Diagnostics Market Overview
8.2. U.K.
8.2.1. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.2.2. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.2.3. U.K. Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.3.2. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.3.3. Germany Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.4.2. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.4.3. France Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.5.2. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.5.3. Spain Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
8.6.2. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
8.6.3. Rest of Europe Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia-Pacific Autoimmune Disease Diagnostics Market By Country
9.1. Asia-Pacific Autoimmune Disease Diagnostics Market Overview
9.2. China
9.2.1. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.2.3. China Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.3.3. Japan Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.4.2. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.4.3. India Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.5.2. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.5.3. Australia Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5.4. 2030
9.6. South Korea
9.6.1. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.6.2. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.6.3. South Korea Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
9.7.2. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
9.7.3. Rest of Asia-Pacific Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.8. Asia-Pacific PEST Analysis
CHAPTER 10. Latin America Autoimmune Disease Diagnostics Market By Country
10.1. Latin America Autoimmune Disease Diagnostics Market Overview
10.2. Brazil
10.2.1. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.2.3. Brazil Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.3.3. Mexico Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
10.4.3. Rest of Latin America Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Autoimmune Disease Diagnostics Market By Country
11.1. Middle East & Africa Autoimmune Disease Diagnostics Market Overview
11.2. GCC
11.2.1. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.2.3. GCC Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.3.3. South Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By Test Type, 2018-2030
11.4.3. Rest of Middle East & Africa Autoimmune Disease Diagnostics Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Autoimmune Disease Diagnostics Market
12.1. Autoimmune Disease Diagnostics Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancement
12.2.3. Mergers And Acquisition In Global Autoimmune Disease Diagnostics Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Abbott Laboratories 2021 Autoimmune Disease Diagnostics Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AstraZeneca
13.3. Beckman Coulter Inc.
13.4. Bio-Rad Laboratories Inc.
13.5. F. Hoffmann-La Roche
13.6. Hemagen Diagnostics Inc.
13.7. Inova Diagnostics Inc.
13.8. Novartis AG
13.9. Pfizer Inc.
13.10. Sanofi-aventis
